masoprocol has been researched along with Lung Injury, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Huang, L; Lin, Y; Lu, Q; Shen, M; Shi, Q; Wang, X; Zhang, J | 1 |
1 other study(ies) available for masoprocol and Lung Injury, Acute
| Article | Year |
|---|---|
A novel nordihydroguaiaretic acid analog, compound 3a, alleviates acute lung injury by exerting antiapoptotic and antiinflammatory effects.
Topics: Acute Lung Injury; Animals; Apoptosis; Inflammation; Lipopolysaccharides; Male; Masoprocol; Mice; Mice, Inbred C57BL; Protective Agents; RAW 264.7 Cells | 2022 |